Lenticule Implantation and Autologous Serum New Approach in Treatment of Adenoviral Keratitis Disease
Adenoviral Keratoconjunctivitis
About this trial
This is an interventional treatment trial for Adenoviral Keratoconjunctivitis
Eligibility Criteria
Inclusion Criteria:
- low transparency of cornea
- low visual acuity
- recurrence keratitis
Exclusion Criteria:
- active anterior segment pathology
- previous corneal or anterior segment surgery
- any infection
Sites / Locations
- Eye Hospital Pristina
Arms of the Study
Arm 1
Other
ReLex Smile surgery
Fresh Corneal Lenticule Implantation using Relex-Smile Surgery We used all preoperative procedures atlas, optic tomography and especially electron microscope. Approximately we planned how much microns we remove and insert with the purpose to remove more dead keratocytes which increase biomechanical instability of corneal metabolism (abnormal increase collagenase activity, decrease proteinase inhibitors, excessive premature keratocyte apoptosis, increase cytokine binding). Fresh Corneal Lenticule and autologous serum contains live stem cells that produce keratocytes, collagen fibers, extracellular matrix which contribute to the regeneration of the cornea, and all this results at increasing of corneal transparency and visual acuity in patients with adenoviral keratitis.